USD $474.00
Prolia, Xgeva (Denosumab) is a medication used to treat bone-related conditions. It is administered as a 60mg/ml solution in a single prefilled syringe, designed for convenient and precise dosing.
Denosumab works by inhibiting the development and activity of osteoclasts, the cells responsible for bone resorption. This action helps to maintain bone density and strength, reducing the risk of fractures and other bone-related issues.
Prolia is primarily used to treat osteoporosis in postmenopausal women and men at high risk of fractures. Xgeva is used to prevent skeletal-related events in patients with bone metastases from solid tumors and to treat giant cell tumor of bone.
Prolia, Xgeva is administered via subcutaneous injection, typically by a healthcare professional. The prefilled syringe ensures accurate dosing and ease of use.
Common side effects of Denosumab may include back pain, muscle pain, and pain in the arms and legs. It is important to discuss potential side effects with a healthcare provider before starting treatment.
Individuals with low blood calcium levels or those who are allergic to any component of the medication should avoid using Denosumab. It is crucial to consult with a healthcare provider to determine suitability.
Patients should ensure adequate intake of calcium and vitamin D during treatment. Regular monitoring of bone mineral density and serum calcium levels is recommended. Inform your healthcare provider of all medications and supplements you are taking to avoid potential interactions.
The prefilled syringe should be stored in a refrigerator, away from light and moisture. Do not freeze. Keep it out of reach of children and use it only as directed by a healthcare professional.
For more detailed information, consult the prescribing information or speak with a healthcare professional. They can provide personalized guidance based on individual health needs and conditions.
Health Guides